Snakebite and Antivenom: Neutralising the Venom

Venom is a cocktail, not a single poison

A snake does not carry one weapon — it carries a pharmacy. Venom is a complex mixture of dozens of proteins: enzymes (phospholipases, metalloproteinases, hyaluronidases) that break down membranes and connective tissue, and small toxins that target specific molecules — ion channels, clotting factors, the neuromuscular junction. Evolution tuned this brew to immobilise prey and begin digesting it before it is even swallowed. That is why a single bite can attack blood, nerve and flesh at the same time, and why the clinical picture depends far more on the species than on the wound itself. Rather than memorise every toxin, it is more useful to group the effects into a few overlapping syndromes and tie each to the snake families that cause it.

Neurotoxic venom: the descending paralysis that kills

Many elapids — cobras, kraits, mambas, and some vipers — carry neurotoxins that attack the neuromuscular junction, the synapse where nerve tells muscle to contract. Some toxins act post-synaptically, plugging the acetylcholine receptor like a curare (the alpha-neurotoxins of cobras); others act pre-synaptically, destroying the nerve terminal so it can no longer release acetylcholine at all (the beta-neurotoxins of kraits). Either way transmission fails, and the failure has a characteristic top-down march: the first muscles to go are the small, constantly-used ones of the eyelids and eyes, giving ptosis (drooping lids) and ophthalmoplegia (frozen eye movements), then the bulbar muscles of speech and swallowing, and finally — the killer — the diaphragm and the muscles of breathing. This is the same neuromuscular junction covered in the Autonomic & Neuromuscular chapter, only here the blockade comes from venom instead of a drug.

Haemotoxic venom: when the blood forgets how to clot

Many vipers wage war on the clotting cascade. Viper venoms are rich in enzymes that hijack the coagulation system. Some directly activate clotting factors or convert fibrinogen, driving the blood to clot uselessly inside the vessels; the body burns through its fibrinogen and platelets trying to keep up until there is nothing left to clot with. The result is venom-induced consumption coagulopathy — a paradox where over-activation leaves the patient unable to clot at all, bleeding from the gums, the bite, old needle sites, the gut, and dangerously into the brain. Thrombocytopenia (a falling platelet count) compounds it. This is the same clotting cascade and platelet biology taught in the Haematology section, deranged here by an enzyme injected through two fangs. At the bedside a single cheap test tells you almost everything: the 20-minute whole-blood clotting test — a few millilitres of the patient's blood left undisturbed in a clean, dry glass tube. If it has not formed a solid clot in twenty minutes, the venom has consumed the clotting system and systemic envenomation is confirmed.

Cytotoxic and systemic effects: the digested limb

Some venoms — many cobras and vipers — are dominated by cytotoxins and tissue-destroying enzymes that turn the bite site into a spreading zone of swelling, blistering, and frank necrosis. The limb tenses as fluid and blood pour into the tissues; if pressure inside a muscle compartment rises high enough to choke its own blood supply, a compartment syndrome develops that can kill the limb even after the venom is neutralised. Beyond the local damage, venom can drive systemic catastrophe: shock from massive fluid shift and vasodilatation, acute kidney injury (AKI) from the combined assault of hypotension, haemolysis, and pigment released by muscle breakdown, rhabdomyolysis from myotoxic venoms, and in a few species direct cardiotoxicity. The kidney injury links to the Renal section, the muscle breakdown and myoglobin to the same rhabdomyolysis pathway seen in other poisonings.

First aid: do less, and do no harm

The most important first-aid instruction is the shortest: reassure the patient, keep them still, and get them to a hospital with antivenom as fast as possible. Immobilise the bitten limb roughly at heart level with a splint, because muscle movement pumps venom into the circulation, and remove rings and tight clothing before swelling sets in. For confirmed neurotoxic elapid bites (where venom spreads mainly through lymph), a firm pressure-immobilisation bandage over the whole limb can slow that spread — but it is not recommended for the necrotic viper bites, where trapping cytotoxin against tissue makes the local damage worse. Fear and adrenaline drive the heart to circulate venom faster, so calming the patient is itself a treatment.

The antidote: antivenom, an antibody that binds the venom

Antivenom is passive immunity, borrowed from an animal. Antivenom is made by injecting a horse or sheep with small, sub-lethal doses of venom; the animal mounts an antibody response, and its plasma is harvested and purified into a product that is either whole IgG or, increasingly, enzyme-cleaved fragments — F(ab′)₂ or the smaller Fab. Infused into a bitten patient, these antibodies do exactly one thing, and do it beautifully: they bind circulating venom molecules and neutralise them, forming immune complexes that are cleared and stopping the venom from reaching its targets. This is the purest example of an antibody antidote, and it sits alongside digoxin-specific Fab in the Enhanced Elimination & Antidotes chapter — the same principle of a designed antibody mopping a toxin out of the blood. Products are monovalent (raised against a single species, used where the culprit snake is known) or polyvalent (a mixture covering several regionally important species, the workhorse when the snake was not seen).

When do you actually give it? Not for every bite — a large fraction of bites are "dry" or involve non-venomous snakes, and antivenom carries real risk. The indication is evidence of systemic envenomation: neurotoxicity (ptosis, bulbar or respiratory weakness), coagulopathy (a non-clotting 20-minute test, spontaneous bleeding), cardiovascular instability, or acute kidney injury — and, in some settings, rapidly progressive severe local swelling. The governing principle is give it early: antivenom neutralises venom that is still circulating, so the sooner it is in, the more it can catch before the toxins bind their targets. Coagulopathy is the effect that most reliably reverses — clotting can restore over hours as the neutralised venom stops consuming factors and the liver replaces them. Established local necrosis, by contrast, does not un-happen, and a fixed pre-synaptic paralysis will not lift just because the last free venom is gone.

The antidote's own dangers: anaphylaxis and serum sickness

Because antivenom is foreign animal protein infused intravenously, it can provoke the immune system it is meant to rescue. Early reactions — occurring during or soon after the infusion — range from urticaria and fever to true anaphylaxis with bronchospasm and shock; this is why the infusion runs slowly under close watch with adrenaline, and, if needed, corticosteroids and antihistamines, at hand. This is the same anaphylaxis and adrenaline covered in the Respiratory and emergency chapters — the airway, breathing and circulation come first, and a severe reaction is treated with adrenaline while the antivenom is paused. A later, slower complication is serum sickness: a type III immune-complex reaction appearing one to two weeks afterward with fever, rash, joint pains and lymphadenopathy, treated with antihistamines and a short course of corticosteroids. Neither risk is a reason to withhold antivenom when systemic envenomation is present — a non-clotting blood test or a failing diaphragm is far more dangerous than the reaction — but both are reasons never to give it casually.